Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
Conditions: Vasodilatory Shock Interventions: Drug: Angiotensin II Injection; Drug: 0.9% sodium chloride injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Conditions: Advanced Malignant Neoplasm Interventions: Drug: TQB3006 tablets Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)
Conditions: Chronic Obstructive Pulmonary Disease Interventions: Drug: Tiotropium Bromide Inhalation Powder; Drug: Spiriva HandiHaler Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: TQB2223 injection; Drug: Penpulimab Injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
Conditions: Non Small Cell Lung Cancer Interventions: Drug: D-1553 Tablet; Drug: Docetaxel injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Conditions: Chronic Graft Versus Host Disease Interventions: Drug: TQ05105 tablets Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Conditions: Advanced Malignant Neoplasm Interventions: Drug: TQB2928 injection; Drug: Penpulimab Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A
Conditions: Hemophilia A Interventions: Drug: Recombinant human activated coagulation factor VIII for injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer Interventions: Drug: AL2846 capsules; Drug: Gemzar Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients
Conditions: Esophageal Cancer; Gastrointestinal Dysfunction Interventions: Other: acupressure Sponsors: CHEN, CHIA-CHEN Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Conditions: Ovarian Cancer; Cervical Cancer Interventions: Drug: Efbemalenograstim Alfa Sponsors: Shandong University; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
Conditions: Myelofibrosis Interventions: Drug: TQ05105 tablets; Drug: TQB3909 tablets Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
Conditions: Psoriasis Interventions: Drug: TQH3906 capsule; Drug: TQH3906 placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
Conditions: Gastric Cancer; Adenocarcinoma of Esophagogastric Junction Interventions: Drug: Anlotinib; Drug: TQB2450; Drug: Albumin-Bound Paclitaxel Sponsors: Peking University; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
Conditions: Malignant Tumor of Liver; Randomized Controlled Trial Interventions: Procedure: NIF image-guided laparoscopic anatomical liver resection with the novel ICG@HSA administration; Procedure: NIF image-guided laparoscopic anatomical liver resection with the guideline-recommended ICG administration Sponsors: West China Hospital; Nanjing Chia-Tai Tianqing Pharmaceutical Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
